1 Department of Pediatric Endocrinology, Barbara Davis Center, University of Colorado Denver, Aurora, Colorado.
2 Department of Computer Science, University of Colorado, Boulder, Colorado.
Diabetes Technol Ther. 2019 Apr;21(4):222-229. doi: 10.1089/dia.2018.0401. Epub 2019 Feb 28.
Continuous glucose monitors (CGM) display real-time glucose values enabling greater glycemic awareness with reduced management burden. Factory-calibrated CGM systems allow for glycemic assessment without the pain and inconvenience of fingerstick glucose testing. Advances in sensor chemistry and CGM algorithms have enabled factory-calibrated systems to have greater accuracy than previous generations of CGM technology. Despite these advances many patients and providers are hesitant about the idea of removing fingerstick testing from their diabetes care. In this commentary, we aim to review the clinical trials on factory-calibrated CGM systems, present the algorithms which facilitate factory-calibrated CGMs to improve accuracy, discuss clinical use of factory-calibrated CGMs, and finally present two cases demonstrating the dangers of utilizing exploits in commercial systems to prolong sensor life.
连续血糖监测仪(CGM)实时显示血糖值,可减轻管理负担并提高血糖意识。经过工厂校准的 CGM 系统无需进行手指血糖检测,即可评估血糖水平,减少了相关的疼痛和不便。传感器化学和 CGM 算法的进步使经过工厂校准的系统比以前几代 CGM 技术具有更高的准确性。尽管取得了这些进步,但许多患者和医护人员仍然对从糖尿病治疗中去除手指血糖检测持犹豫态度。在本评论中,我们旨在回顾有关工厂校准 CGM 系统的临床试验,介绍有助于提高准确性的算法,讨论工厂校准 CGM 的临床应用,最后展示两个案例,说明利用商业系统中的漏洞延长传感器寿命的危险。